๐ŸŽ—๏ธ OncologyCapsule

    Nilotinib

    Nilotinib

    A BCR-ABL tyrosine kinase inhibitor used to treat Philadelphia chromosome-positive chronic myeloid leukemia in newly diagnosed patients or those resistant to or intolerant of imatinib.

    Form

    Capsule

    Uses

    2

    Side effects

    6

    Category

    Oncology

    01

    What is Nilotinib used for?

    • Treatment of newly diagnosed Ph+ CML in chronic phase
    • Treatment of chronic or accelerated phase Ph+ CML resistant to or intolerant of prior imatinib therapy
    02

    Nilotinib side effects

    Common side effects of Nilotinib include:

    Myelosuppression
    QT prolongation
    Rash
    Nausea
    Headache
    Elevated liver enzymes
    CommonModerateLess common
    03

    Nilotinib warnings & precautions

    • Prolongs QT interval; sudden deaths have been reported
    • Obtain baseline ECG and monitor periodically; correct hypokalemia and hypomagnesemia before treatment

    Loading FDA dataโ€ฆ

    04

    Frequently asked questions

    05

    Related medications

    Share

    Share this drug info.

    Help friends and family understand Nilotinib in plain language.

    Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.